Loading…

Efficacy of probiotics supplementation in amelioration of celiac disease symptoms and enhancement of immune system

Patients with celiac disease (CD) have a mucosal layer that is unable to regulate the gut microbiota, leaving the host vulnerable to dangerous infections and antigens. When compared to healthy people, this dysbiosis is marked by a decrease in intra- and intergeneric biodiversity, which demonstrates...

Full description

Saved in:
Bibliographic Details
Published in:World journal of clinical cases 2023-11, Vol.11 (32), p.7741-7744
Main Authors: Moawad, Mostafa Hossam-Eldin, Alkhawaldeh, Ibraheem M, Naswhan, Abdulqadir J
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c277t-3285df7b5d3abba3f28a358540aa5df4a8027d4c283aaf14678ae011bc2334063
cites cdi_FETCH-LOGICAL-c277t-3285df7b5d3abba3f28a358540aa5df4a8027d4c283aaf14678ae011bc2334063
container_end_page 7744
container_issue 32
container_start_page 7741
container_title World journal of clinical cases
container_volume 11
creator Moawad, Mostafa Hossam-Eldin
Alkhawaldeh, Ibraheem M
Naswhan, Abdulqadir J
description Patients with celiac disease (CD) have a mucosal layer that is unable to regulate the gut microbiota, leaving the host vulnerable to dangerous infections and antigens. When compared to healthy people, this dysbiosis is marked by a decrease in intra- and intergeneric biodiversity, which demonstrates an imbalance between helpful bacteria and possibly harmful or proinflammatory species. The early gut microbiota is influenced by the genotype of newborns with the HLA-DQ2 haplotypes, and this may modify how gluten is handled in the intestinal lumen, polarize innate or adaptive immune responses, and result in glutensensitive enteropathy. The outcome of gluten digestion can vary depending on the composition of the intestinal gut bacteria and the partial conversion of gluten into peptides larger than ten amino acids in the small intestines, which can be immunogenic. In the small intestine, 114 different bacterial strains belonging to 32 different species have 27 of them exhibiting peptidolytic activity. Thus, the individual risk of developing a gluten-related illness is further influenced by microbial composition and gluten degrading capacity. The conclusion that and spp. may be used as a probiotic supplement in CD patients is based on their shared possession of the most extensive peptidolytic and proteolytic activity thought to be engaged in the breakdown of gluten among all potential bacterial genera present in the gut microbiota. In children with CD autoimmunity, daily oral dose of HEAL9 and 8700:2 was found to modify the peripheral immune response. strains have demonstrated a beneficial effect on reducing pro-inflammatory cytokine TNF- production in CD children on gluten-free diets.
doi_str_mv 10.12998/wjcc.v11.i32.7741
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2902939251</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2902939251</sourcerecordid><originalsourceid>FETCH-LOGICAL-c277t-3285df7b5d3abba3f28a358540aa5df4a8027d4c283aaf14678ae011bc2334063</originalsourceid><addsrcrecordid>eNpNkMtOwzAQRS0EolXpD7BAXrJJ8COJnSWqykNCYgNra-LYwlWchDgB9e9x2oJYzYx87shzELqmJKWsLOXd907r9IvS1HGWCpHRM7RknIhElgU5_9cv0DqEHSGEUpLTgl-iBZdEcEHYEg1ba50Gvcedxf3QVa4bnQ44TH3fGG_aEUbXtdi1GLxpXDcc50jrOILGtQsGgsFh7_ux8wFDW2PTfkCrD_kZdd5P7YyE0fgrdGGhCWZ9qiv0_rB92zwlL6-Pz5v7l0QzIcaEM5nXVlR5zaGqgFsmgecyzwhAfMhAEibqTDPJASzNCiHBxBsrzTjPSMFX6Pa4N571OZkwKu9C_HQDremmoFhJWMlLltOIsiOqhy6EwVjVD87DsFeUqINuNetWUbeKutWsO4ZuTvunypv6L_Irl_8AYhl_DA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2902939251</pqid></control><display><type>article</type><title>Efficacy of probiotics supplementation in amelioration of celiac disease symptoms and enhancement of immune system</title><source>PubMed Central</source><creator>Moawad, Mostafa Hossam-Eldin ; Alkhawaldeh, Ibraheem M ; Naswhan, Abdulqadir J</creator><creatorcontrib>Moawad, Mostafa Hossam-Eldin ; Alkhawaldeh, Ibraheem M ; Naswhan, Abdulqadir J</creatorcontrib><description>Patients with celiac disease (CD) have a mucosal layer that is unable to regulate the gut microbiota, leaving the host vulnerable to dangerous infections and antigens. When compared to healthy people, this dysbiosis is marked by a decrease in intra- and intergeneric biodiversity, which demonstrates an imbalance between helpful bacteria and possibly harmful or proinflammatory species. The early gut microbiota is influenced by the genotype of newborns with the HLA-DQ2 haplotypes, and this may modify how gluten is handled in the intestinal lumen, polarize innate or adaptive immune responses, and result in glutensensitive enteropathy. The outcome of gluten digestion can vary depending on the composition of the intestinal gut bacteria and the partial conversion of gluten into peptides larger than ten amino acids in the small intestines, which can be immunogenic. In the small intestine, 114 different bacterial strains belonging to 32 different species have 27 of them exhibiting peptidolytic activity. Thus, the individual risk of developing a gluten-related illness is further influenced by microbial composition and gluten degrading capacity. The conclusion that and spp. may be used as a probiotic supplement in CD patients is based on their shared possession of the most extensive peptidolytic and proteolytic activity thought to be engaged in the breakdown of gluten among all potential bacterial genera present in the gut microbiota. In children with CD autoimmunity, daily oral dose of HEAL9 and 8700:2 was found to modify the peripheral immune response. strains have demonstrated a beneficial effect on reducing pro-inflammatory cytokine TNF- production in CD children on gluten-free diets.</description><identifier>ISSN: 2307-8960</identifier><identifier>EISSN: 2307-8960</identifier><identifier>DOI: 10.12998/wjcc.v11.i32.7741</identifier><identifier>PMID: 38073702</identifier><language>eng</language><publisher>United States</publisher><ispartof>World journal of clinical cases, 2023-11, Vol.11 (32), p.7741-7744</ispartof><rights>The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c277t-3285df7b5d3abba3f28a358540aa5df4a8027d4c283aaf14678ae011bc2334063</citedby><cites>FETCH-LOGICAL-c277t-3285df7b5d3abba3f28a358540aa5df4a8027d4c283aaf14678ae011bc2334063</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38073702$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moawad, Mostafa Hossam-Eldin</creatorcontrib><creatorcontrib>Alkhawaldeh, Ibraheem M</creatorcontrib><creatorcontrib>Naswhan, Abdulqadir J</creatorcontrib><title>Efficacy of probiotics supplementation in amelioration of celiac disease symptoms and enhancement of immune system</title><title>World journal of clinical cases</title><addtitle>World J Clin Cases</addtitle><description>Patients with celiac disease (CD) have a mucosal layer that is unable to regulate the gut microbiota, leaving the host vulnerable to dangerous infections and antigens. When compared to healthy people, this dysbiosis is marked by a decrease in intra- and intergeneric biodiversity, which demonstrates an imbalance between helpful bacteria and possibly harmful or proinflammatory species. The early gut microbiota is influenced by the genotype of newborns with the HLA-DQ2 haplotypes, and this may modify how gluten is handled in the intestinal lumen, polarize innate or adaptive immune responses, and result in glutensensitive enteropathy. The outcome of gluten digestion can vary depending on the composition of the intestinal gut bacteria and the partial conversion of gluten into peptides larger than ten amino acids in the small intestines, which can be immunogenic. In the small intestine, 114 different bacterial strains belonging to 32 different species have 27 of them exhibiting peptidolytic activity. Thus, the individual risk of developing a gluten-related illness is further influenced by microbial composition and gluten degrading capacity. The conclusion that and spp. may be used as a probiotic supplement in CD patients is based on their shared possession of the most extensive peptidolytic and proteolytic activity thought to be engaged in the breakdown of gluten among all potential bacterial genera present in the gut microbiota. In children with CD autoimmunity, daily oral dose of HEAL9 and 8700:2 was found to modify the peripheral immune response. strains have demonstrated a beneficial effect on reducing pro-inflammatory cytokine TNF- production in CD children on gluten-free diets.</description><issn>2307-8960</issn><issn>2307-8960</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpNkMtOwzAQRS0EolXpD7BAXrJJ8COJnSWqykNCYgNra-LYwlWchDgB9e9x2oJYzYx87shzELqmJKWsLOXd907r9IvS1HGWCpHRM7RknIhElgU5_9cv0DqEHSGEUpLTgl-iBZdEcEHYEg1ba50Gvcedxf3QVa4bnQ44TH3fGG_aEUbXtdi1GLxpXDcc50jrOILGtQsGgsFh7_ux8wFDW2PTfkCrD_kZdd5P7YyE0fgrdGGhCWZ9qiv0_rB92zwlL6-Pz5v7l0QzIcaEM5nXVlR5zaGqgFsmgecyzwhAfMhAEibqTDPJASzNCiHBxBsrzTjPSMFX6Pa4N571OZkwKu9C_HQDremmoFhJWMlLltOIsiOqhy6EwVjVD87DsFeUqINuNetWUbeKutWsO4ZuTvunypv6L_Irl_8AYhl_DA</recordid><startdate>20231116</startdate><enddate>20231116</enddate><creator>Moawad, Mostafa Hossam-Eldin</creator><creator>Alkhawaldeh, Ibraheem M</creator><creator>Naswhan, Abdulqadir J</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20231116</creationdate><title>Efficacy of probiotics supplementation in amelioration of celiac disease symptoms and enhancement of immune system</title><author>Moawad, Mostafa Hossam-Eldin ; Alkhawaldeh, Ibraheem M ; Naswhan, Abdulqadir J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c277t-3285df7b5d3abba3f28a358540aa5df4a8027d4c283aaf14678ae011bc2334063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Moawad, Mostafa Hossam-Eldin</creatorcontrib><creatorcontrib>Alkhawaldeh, Ibraheem M</creatorcontrib><creatorcontrib>Naswhan, Abdulqadir J</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>World journal of clinical cases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moawad, Mostafa Hossam-Eldin</au><au>Alkhawaldeh, Ibraheem M</au><au>Naswhan, Abdulqadir J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy of probiotics supplementation in amelioration of celiac disease symptoms and enhancement of immune system</atitle><jtitle>World journal of clinical cases</jtitle><addtitle>World J Clin Cases</addtitle><date>2023-11-16</date><risdate>2023</risdate><volume>11</volume><issue>32</issue><spage>7741</spage><epage>7744</epage><pages>7741-7744</pages><issn>2307-8960</issn><eissn>2307-8960</eissn><abstract>Patients with celiac disease (CD) have a mucosal layer that is unable to regulate the gut microbiota, leaving the host vulnerable to dangerous infections and antigens. When compared to healthy people, this dysbiosis is marked by a decrease in intra- and intergeneric biodiversity, which demonstrates an imbalance between helpful bacteria and possibly harmful or proinflammatory species. The early gut microbiota is influenced by the genotype of newborns with the HLA-DQ2 haplotypes, and this may modify how gluten is handled in the intestinal lumen, polarize innate or adaptive immune responses, and result in glutensensitive enteropathy. The outcome of gluten digestion can vary depending on the composition of the intestinal gut bacteria and the partial conversion of gluten into peptides larger than ten amino acids in the small intestines, which can be immunogenic. In the small intestine, 114 different bacterial strains belonging to 32 different species have 27 of them exhibiting peptidolytic activity. Thus, the individual risk of developing a gluten-related illness is further influenced by microbial composition and gluten degrading capacity. The conclusion that and spp. may be used as a probiotic supplement in CD patients is based on their shared possession of the most extensive peptidolytic and proteolytic activity thought to be engaged in the breakdown of gluten among all potential bacterial genera present in the gut microbiota. In children with CD autoimmunity, daily oral dose of HEAL9 and 8700:2 was found to modify the peripheral immune response. strains have demonstrated a beneficial effect on reducing pro-inflammatory cytokine TNF- production in CD children on gluten-free diets.</abstract><cop>United States</cop><pmid>38073702</pmid><doi>10.12998/wjcc.v11.i32.7741</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2307-8960
ispartof World journal of clinical cases, 2023-11, Vol.11 (32), p.7741-7744
issn 2307-8960
2307-8960
language eng
recordid cdi_proquest_miscellaneous_2902939251
source PubMed Central
title Efficacy of probiotics supplementation in amelioration of celiac disease symptoms and enhancement of immune system
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T18%3A57%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20of%20probiotics%20supplementation%20in%20amelioration%20of%20celiac%20disease%20symptoms%20and%20enhancement%20of%20immune%20system&rft.jtitle=World%20journal%20of%20clinical%20cases&rft.au=Moawad,%20Mostafa%20Hossam-Eldin&rft.date=2023-11-16&rft.volume=11&rft.issue=32&rft.spage=7741&rft.epage=7744&rft.pages=7741-7744&rft.issn=2307-8960&rft.eissn=2307-8960&rft_id=info:doi/10.12998/wjcc.v11.i32.7741&rft_dat=%3Cproquest_cross%3E2902939251%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c277t-3285df7b5d3abba3f28a358540aa5df4a8027d4c283aaf14678ae011bc2334063%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2902939251&rft_id=info:pmid/38073702&rfr_iscdi=true